Mouse models in COVID-19 research: analyzing the adaptive immune response

Med Microbiol Immunol. 2023 Apr;212(2):165-183. doi: 10.1007/s00430-022-00735-8. Epub 2022 Jun 4.

Abstract

The emergence of SARS-CoV-2, the severe acute respiratory syndrome coronavirus type 2 causing the COVID-19 pandemic, resulted in a major necessity for scientific countermeasures. Investigations revealing the exact mechanisms of the SARS-CoV-2 pathogenesis provide the basis for the development of therapeutic measures and protective vaccines against COVID-19. Animal models are inevitable for infection and pre-clinical vaccination studies as well as therapeutic testing. A well-suited animal model, mimicking the pathology seen in human COVID-19 patients, is an important basis for these investigations. Several animal models were already used during SARS-CoV-2 studies with different clinical outcomes after SARS-CoV-2 infection. Here, we give an overview of different animal models used in SARS-CoV-2 infection studies with a focus on the mouse model. Mice provide a well-established animal model for laboratory use and several different mouse models have been generated and are being used in SARS-CoV-2 studies. Furthermore, the analysis of SARS-CoV-2-specific T cells during infection and in vaccination studies in mice is highlighted.

Keywords: COVID-19; Mouse models; SARS-CoV-2; Specific T cells.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • Animals
  • COVID-19 Vaccines
  • COVID-19*
  • Disease Models, Animal
  • Humans
  • Mice
  • Pandemics / prevention & control
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines

Grants and funding